Obermatt
See Similar Stocks →

EssilorLuxottica

PAR:EL · FR0000121667
Health Care Equipment & SuppliesXX-Large

360

55
EV / EBIT27
Price / Owner Earnings17
Owner Earnings Yield49
Dividend Yield69
Price/Sales46
EV / Gross Profit55
Price/Book64
Return on Capital57
Cash Return on Capital63
Return on Equity53
EBIT Margin65
Gross Profitability48
Cash Conversion60
Accruals34
Owner Earnings Margin73
Sales growth82
Profit Growth98
Long-Term EPS Growth73
Owner Earnings Growth58
Reinvestment48
Price momentum15
Debt load61
Refinancing22
Debt Payback42
Liquidity68
Analyst ratings75
Opinion Changes66
Price Target Upside88
Market mood68
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

EssilorLuxottica clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryFrance
IndustryHealth Care Equipment & Supplies
SizeXX-Large
TypePublic Company
ExchangeENXTPA
Founded1971
Employees16,010
Websiteessilorluxottica.com
ISINFR0000121667
Last UpdateApr 2, 2026
Indices
CAC 40 (France)CAC All (France)EURO STOXX 50 (European Union)SBF 120 (France)
Themes
OphthalmologyAugmented RealityDetectors, Sensors and MemsHealth DiagnosticsWearablesEyewearHealth CareProduct Design

Description

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses. Business Segments The company operates in various business segments that allow it to maintain a robust presence in the global eyewear…

Analysis

Middle-of-the-road

EssilorLuxottica Société anonyme sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is expensive. The owner-earnings multiple stands at 28.0×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 11% a year, against analyst forecasts of 12%. The price, in other words, assumes less than the experts do.

Growth is moderate; the safety picture is adequate. The company scores 10/20 on our value-creation score: creating some value.

Flags to be aware of: A large part of the company's book value is the price paid for past acquisitions. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
86
2023202420252026

All-time high

100

Jan 2023

All-time low

25

Jun 2025

Average rank

67

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
46
25
52
64
Price/Earnings
34
23
53
55
Price/Book
64
53
84
89
Dividend Yield
69
61
65
76
Value (overall)
53
34
56
79

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare EssilorLuxottica with its peers
Carl Zeiss Meditec
GER:AFX
50
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Jenoptik
GER:JEN
74
CountryGermany
IndustryElectronic Equipment, Instruments & Components
SizeMedium
Full Stock Analysis →
Alcon
VTX:ALC
51
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Datalogic
MIL:DAL
40
CountryItaly
IndustryElectronic Equipment, Instruments & Components
SizeSmall
Full Stock Analysis →
Siemens Healthineers
GER:SHL
17
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Sartorius
GER:SRT
11
CountryGermany
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →